IRIS Accounts Production v24.1.4.33 12813332 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh128133322023-03-31128133322024-03-31128133322023-04-012024-03-31128133322022-03-31128133322022-04-012023-03-31128133322023-03-3112813332ns15:EnglandWales2023-04-012024-03-3112813332ns14:PoundSterling2023-04-012024-03-3112813332ns10:Director12023-04-012024-03-3112813332ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3112813332ns10:SmallEntities2023-04-012024-03-3112813332ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3112813332ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3112813332ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3112813332ns10:FullAccounts2023-04-012024-03-3112813332ns10:Director22023-04-012024-03-3112813332ns10:RegisteredOffice2023-04-012024-03-3112813332ns5:CurrentFinancialInstruments2024-03-3112813332ns5:CurrentFinancialInstruments2023-03-3112813332ns5:ShareCapital2024-03-3112813332ns5:ShareCapital2023-03-3112813332ns5:RetainedEarningsAccumulatedLosses2024-03-3112813332ns5:RetainedEarningsAccumulatedLosses2023-03-3112813332ns5:PlantMachinery2023-03-3112813332ns5:PlantMachinery2023-04-012024-03-3112813332ns5:PlantMachinery2024-03-3112813332ns5:PlantMachinery2023-03-3112813332ns5:AdditionsToInvestments2024-03-3112813332ns5:CostValuation2024-03-3112813332ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3112813332ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-31
REGISTERED NUMBER: 12813332 (England and Wales)



















Unaudited Financial Statements

for the Year Ended 31 March 2024

for

GALL CARDIOLOGY LTD

GALL CARDIOLOGY LTD (REGISTERED NUMBER: 12813332)

Contents of the Financial Statements
for the Year Ended 31 March 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


GALL CARDIOLOGY LTD

Company Information
for the Year Ended 31 March 2024







DIRECTORS: Dr N P Gall
Mrs E A Gall





REGISTERED OFFICE: 2 St Marys Road
Tonbridge
Kent
TN9 2LB





REGISTERED NUMBER: 12813332 (England and Wales)





ACCOUNTANTS: Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB

GALL CARDIOLOGY LTD (REGISTERED NUMBER: 12813332)

Balance Sheet
31 March 2024

2024 2023
Notes £ £
FIXED ASSETS
Property, plant and equipment 4 3,595 4,794
Investments 5 73,000 -
76,595 4,794

CURRENT ASSETS
Debtors 6 49,116 14,739
Cash at bank 178,601 198,968
227,717 213,707
CREDITORS
Amounts falling due within one year 7 (64,398 ) (39,724 )
NET CURRENT ASSETS 163,319 173,983
TOTAL ASSETS LESS CURRENT
LIABILITIES

239,914

178,777

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 239,814 178,677
SHAREHOLDERS' FUNDS 239,914 178,777

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

GALL CARDIOLOGY LTD (REGISTERED NUMBER: 12813332)

Balance Sheet - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 6 August 2024 and were signed on its behalf by:





Dr N P Gall - Director


GALL CARDIOLOGY LTD (REGISTERED NUMBER: 12813332)

Notes to the Financial Statements
for the Year Ended 31 March 2024


1. STATUTORY INFORMATION

Gall Cardiology Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

GALL CARDIOLOGY LTD (REGISTERED NUMBER: 12813332)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024


2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. PROPERTY, PLANT AND EQUIPMENT
Plant and
machinery
etc
£
COST
At 1 April 2023
and 31 March 2024 8,258
DEPRECIATION
At 1 April 2023 3,464
Charge for year 1,199
At 31 March 2024 4,663
NET BOOK VALUE
At 31 March 2024 3,595
At 31 March 2023 4,794

5. FIXED ASSET INVESTMENTS
Other
investments
£
COST
Additions 73,000
At 31 March 2024 73,000
NET BOOK VALUE
At 31 March 2024 73,000

GALL CARDIOLOGY LTD (REGISTERED NUMBER: 12813332)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024


6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£ £
Trade debtors 48,119 14,739
Other debtors 997 -
49,116 14,739

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£ £
Tax 60,663 37,449
Directors' current accounts 1,623 877
Accrued expenses 2,112 1,398
64,398 39,724